| Name | Luther Manor |
|---|---|
| Location | 4545 N 92nd St, Milwaukee, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 152 |
| Occupancy Rate | 58.68% |
| Medicare ID (CCN) | 525588 |
| Legal Business Name | United Lutheran Program For The Aging, Inc |
| Ownership Type | Non Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new German study published on the preprint server bioRxiv* in June 2020 shows that the drug remdesivir can reduce the replication of SARS-CoV-2 in human intestinal organoids.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Aging will affect all of us. Fillers are most commonly used to fill the deep lines around the mouth. Dr. Hardaway, a prominent Farmington Hills, Michigan plastic surgeon states that many patients now prefer to have their own fat injected to fill those unwanted wrinkles.
INTEGRA announces that their VIAFLO ASSIST personal pipetting assistant has been optimized for use with Linkage Biosciences LinkSēq™ tissue typing products.
Traumatic brain injury (TBI) is a major cause of mortality and morbidity, often causing lifelong disability for those who survive. Treatment is limited to supportive care, but stem cell therapy has received recent attention as a way to promote recovery for injuries to the central nervous system (CNS). In this study, researchers transplanted human neural stem cells (hNSCs) into the brains of mice modeled with TBI to investigate whether the hosts' immune systems and the stem cells acting in concert would enhance repair.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $39488 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 11.59 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.26 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 96.72 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.07 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.52 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.32 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.76 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.64 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.26 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 73.89 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.76 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 39.51 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.92 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.55 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 90 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 59.1 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 73.35 | 82.93 |
News Archive
A new German study published on the preprint server bioRxiv* in June 2020 shows that the drug remdesivir can reduce the replication of SARS-CoV-2 in human intestinal organoids.
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Aging will affect all of us. Fillers are most commonly used to fill the deep lines around the mouth. Dr. Hardaway, a prominent Farmington Hills, Michigan plastic surgeon states that many patients now prefer to have their own fat injected to fill those unwanted wrinkles.
INTEGRA announces that their VIAFLO ASSIST personal pipetting assistant has been optimized for use with Linkage Biosciences LinkSēq™ tissue typing products.
Traumatic brain injury (TBI) is a major cause of mortality and morbidity, often causing lifelong disability for those who survive. Treatment is limited to supportive care, but stem cell therapy has received recent attention as a way to promote recovery for injuries to the central nervous system (CNS). In this study, researchers transplanted human neural stem cells (hNSCs) into the brains of mice modeled with TBI to investigate whether the hosts' immune systems and the stem cells acting in concert would enhance repair.
› Verified 6 days ago
Eastcastle Pl Bradford Ter Conv Ctr Location: 2505 E Bradford Ave, Milwaukee, Wisconsin 53211 Phone: (414) 963-6151 | |
Jewish Home And Care Center Location: 1414 N Prospect Ave, Milwaukee, Wisconsin 53202 Phone: (414) 276-2627 | |
Villa At Bradley Estates (the) Location: 6735 W Bradley Rd, Milwaukee, Wisconsin 53223 Phone: (414) 354-3300 | |
Maple Ridge Health Services Location: 2730 W Ramsey Ave, Milwaukee, Wisconsin 53221 Phone: (414) 282-2600 | |